What changed in BillionToOne, Inc.'s 2025 10-K compared to 2024?

Across the narrative sections we track, BillionToOne, Inc. (BLLN) added 0 paragraphs, removed 0, and edited 0 between the 2024 and 2025 10-K filings. The biggest movers are .

Where does this BLLN 10-K diff come from?

The source filings are BillionToOne, Inc.'s official 2024 and 2025 Form 10-K annual reports from SEC EDGAR. 10q10k.net parses each filing, aligns paragraphs by section (Item 1, 1A, 1C, 2, 3, 7, 7A), and highlights every added, removed and edited sentence side-by-side.

BillionToOne, Inc.BLLNEarnings & Financial Report

Nasdaq · Health Care · Services-Medical Laboratories

Deep Analysis

BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.

What changed in BillionToOne, Inc.'s 10-K — 2024 vs 2025

No meaningful paragraph-level changes detected in the compared sections. Either the two filings are nearly identical or the sections did not parse.